Scientists long pictured early life as a simple starter set for RNA, not a materials science playground. But new preprint research posted to bioRxiv on July 1 challenges that. According to the study, naturally occurring RNA molecules can fold into large, sophisticated 3D configurations, including long filaments and cages as large as common viruses.

The specific punchline is bigger than it sounds: some RNA cages assemble into an icosahedron, a 3D shape built from 20 equilateral triangles, resembling a soccer ball. Many viruses package their genomes into protein-based icosahedra called capsids. That raises a live question for origin-of-life researchers: if RNA can make icosahedral cages, could RNA in an “RNA world” have packaged genetic information before DNA and protein took over?

To understand why decision-makers in biotech and adjacent platforms should care, you have to zoom out to how the field frames the dawn of life. The RNA world hypothesis proposes that RNA-based life-forms preceded modern ones, with RNA serving two jobs at once: storing genetic information and catalyzing reactions as stand-in enzymes. In modern cells, RNA still plays major roles, but DNA and protein dominate as primary genetic material and primary enzyme machinery.

A common reason scientists expected RNA to stay “small” is chemistry. Proteins can fold into more diverse figures because they are made from 20 types of subunits, amino acids, each with its own structure. RNA, by comparison, is built from only four nucleotides, which all adopt similar shapes. That limitation led to an assumption that only proteins had enough structural variety to build large, complex assemblies.

This new work aims at that assumption directly. The researchers hypothesized that RNA molecules could link together if they carried sequences that fold into “kissing stem loops.” The idea is straightforward: an RNA strand folds over on itself, forming a loop that resembles a shoelace loop. When loops from different RNA molecules can bind, the molecules “kiss” and can link into larger complexes. After sifting through many RNA sequences, the team found a family of RNA molecules encoded by bacteriophages, viruses that infect bacteria, that form these structures.

They then did the three-step lab sequence that turns a hypothesis into a structural claim. They purified several RNA molecules in the lab, allowed them to assemble in a dish, and captured their structures using cryo-electron microscopy. The results: some RNAs formed long filaments that resembled protein-based filaments such as the cellular cytoskeleton, a scaffold involved in shaping and moving cells. Other RNAs assembled into cages as large as common viruses. For those cages, the icosahedral arrangement showed up, linking an RNA architecture to a shape long associated with protein capsids.

Now comes the critical limitation, and it matters for how confidently the story should be used in strategy decks. The paper demonstrates that RNA had the capacity to assemble into these elaborate structures during the RNA world, Lin Huang said in comments to Live Science, but the research does not prove it actually happened. The environment is the question. Anna Medvegy, an evolutionary biologist at Eötvös Loránd University in Hungary, who was not involved in the work, flagged this directly: can these structures form in the environmental parameters that the RNA world is assumed to have had, such as high temperatures and low pH?

Medvegy’s point is the kind that boards care about even when it’s about prehistoric chemistry. For the RNA world hypothesis to strengthen, scientists would need to recreate likely dawn-of-life conditions and still observe the structures taking shape. The new preprint also reports that while the RNA cages and filaments were large, Huang’s team generated them using only short RNA strands, each no longer than 200 subunits. Medvegy noted that long RNAs are susceptible to breaking. If short strands can assemble into these multi-tiered structures, that improves the plausibility that such assemblies could have existed in the RNA world.

There is another practical next step that affects both origin-of-life credibility and future biotech translation. So far, the team has only seen these structures form in a lab dish. They still need to determine whether factors inside bacteriophage-infected bacteria, including proteins, would disrupt or enable formation inside cells. In business terms: in vitro success does not guarantee in vivo stability. For any organization watching RNA therapeutics, delivery, or synthetic biology, this is the same gap that repeatedly shows up when moving from bench conditions to living systems.

Even so, the work is not only a history-of-life argument. Huang thinks the RNA cages could have potential applications in biotechnology. He points to efforts to use DNA folded into “DNA origami” to deliver drugs into cells, and suggests RNA, DNA’s older cousin, could one day play a similar role in medicine. If RNA can be programmed to assemble into defined large structures like filaments and cages, that expands the toolkit for targeting, encapsulation, and delivery concepts that have already gained traction in DNA origami and other nucleic-acid engineering approaches.

For executives and investors tracking early-stage platform science, the strategic stake is simple: structural capability changes what RNA can be imagined to do. If RNA can build virus-like capsid geometries and cytoskeleton-like filaments using kissing stem loops, the “RNA is too limited” narrative gets harder to maintain. Whether the RNA world ever happened is still an open question. But the constraints have shifted, and once the constraints shift, the opportunity landscape shifts with them.